0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Competent Cells - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-2G9608
Home | Market Reports | Science
Global Competent Cells Market Insights and Forecast to 2028
BUY CHAPTERS

Competent Cells - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-2G9608
Report
November 2023
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Competent Cells - Market Size

The global Competent Cells market size is expected to reach US$ 3782 million by 2029, growing at a CAGR of 9.5% from 2023 to 2029.

Competent Cells -  Market

Competent Cells - Market

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
The market is mainly driven by the significant applications of Competent Cells in various end use industries. The expanding demands from the Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning and High-Throughput Cloning, are propelling Competent Cells market. Chemically Competent Cells, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Electrocompetent Cells segment is estimated at % CAGR for the next seven-year period.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Competent Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Competent Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Competent Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Competent Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Competent Cells covered in this report include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc.
The global Competent Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems

Scope of Competent Cells - Market Report

Report Metric Details
Report Name Competent Cells - Market
Forecasted market size in 2029 US$ 3782 million
CAGR 9.5%
Forecasted years 2023 - 2029
Global Competent Cells market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Competent Cells market, Segment by Type:
  • Chemically Competent Cells
  • Electrocompetent Cells
Global Competent Cells market, by Application
  • Subcloning & Routine Cloning
  • Phage Display Library Construction
  • Toxic/Unstable DNA Cloning
  • High-Throughput Cloning
  • Protein Expression
  • Mutagenesis
  • Single-Stranded DNA Production
  • Bacmid Creation
  • Cre-Lox Recombination (PIR1/PIR2)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of Competent Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Competent Cells - Market size in 2029?

Ans: The Competent Cells - Market size in 2029 will be US$ 3782 million.

What is the market share of major companies in Competent Cells - Market?

Ans: Global top four manufacturers hold a share nearly 30%.

What is the Competent Cells - Market share by type?

Ans: In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%.

What are the Application segmentation covered in the Competent Cells - Market report?

Ans: The Applications covered in the Competent Cells - Market report are Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded DNA Production, Bacmid Creation, Cre-Lox Recombination (PIR1/PIR2)

What are the Type segmentation covered in the Competent Cells - Market report?

Ans: The Types covered in the Competent Cells - Market report are Chemically Competent Cells, Electrocompetent Cells

1 Market Overview of Competent Cells
1.1 Competent Cells Market Overview
1.1.1 Competent Cells Product Scope
1.1.2 Competent Cells Market Status and Outlook
1.2 Global Competent Cells Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Competent Cells Market Size by Region (2018-2029)
1.4 Global Competent Cells Historic Market Size by Region (2018-2023)
1.5 Global Competent Cells Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Competent Cells Market Size (2018-2029)
1.6.1 North America Competent Cells Market Size (2018-2029)
1.6.2 Europe Competent Cells Market Size (2018-2029)
1.6.3 Asia-Pacific Competent Cells Market Size (2018-2029)
1.6.4 Latin America Competent Cells Market Size (2018-2029)
1.6.5 Middle East & Africa Competent Cells Market Size (2018-2029)
2 Competent Cells Market by Type
2.1 Introduction
2.1.1 Chemically Competent Cells
2.1.2 Electrocompetent Cells
2.2 Global Competent Cells Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Competent Cells Historic Market Size by Type (2018-2023)
2.2.2 Global Competent Cells Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Competent Cells Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Competent Cells Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Competent Cells Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Competent Cells Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Competent Cells Revenue Breakdown by Type (2018-2029)
3 Competent Cells Market Overview by Application
3.1 Introduction
3.1.1 Subcloning & Routine Cloning
3.1.2 Phage Display Library Construction
3.1.3 Toxic/Unstable DNA Cloning
3.1.4 High-Throughput Cloning
3.1.5 Protein Expression
3.1.6 Mutagenesis
3.1.7 Single-Stranded DNA Production
3.1.8 Bacmid Creation
3.1.9 Cre-Lox Recombination (PIR1/PIR2)
3.2 Global Competent Cells Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Competent Cells Historic Market Size by Application (2018-2023)
3.2.2 Global Competent Cells Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Competent Cells Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Competent Cells Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Competent Cells Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Competent Cells Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Competent Cells Revenue Breakdown by Application (2018-2029)
4 Competent Cells Competition Analysis by Players
4.1 Global Competent Cells Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Competent Cells as of 2022)
4.3 Date of Key Players Enter into Competent Cells Market
4.4 Global Top Players Competent Cells Headquarters and Area Served
4.5 Key Players Competent Cells Product Solution and Service
4.6 Competitive Status
4.6.1 Competent Cells Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck KGaA
5.1.1 Merck KGaA Profile
5.1.2 Merck KGaA Main Business
5.1.3 Merck KGaA Competent Cells Products, Services and Solutions
5.1.4 Merck KGaA Competent Cells Revenue (US$ Million) & (2018-2023)
5.1.5 Merck KGaA Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Competent Cells Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Competent Cells Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Agilent Technologies
5.3.1 Agilent Technologies Profile
5.3.2 Agilent Technologies Main Business
5.3.3 Agilent Technologies Competent Cells Products, Services and Solutions
5.3.4 Agilent Technologies Competent Cells Revenue (US$ Million) & (2018-2023)
5.3.5 Takara Bio Recent Developments
5.4 Takara Bio
5.4.1 Takara Bio Profile
5.4.2 Takara Bio Main Business
5.4.3 Takara Bio Competent Cells Products, Services and Solutions
5.4.4 Takara Bio Competent Cells Revenue (US$ Million) & (2018-2023)
5.4.5 Takara Bio Recent Developments
5.5 Promega Corporation
5.5.1 Promega Corporation Profile
5.5.2 Promega Corporation Main Business
5.5.3 Promega Corporation Competent Cells Products, Services and Solutions
5.5.4 Promega Corporation Competent Cells Revenue (US$ Million) & (2018-2023)
5.5.5 Promega Corporation Recent Developments
5.6 Beijing TransGen Biotech
5.6.1 Beijing TransGen Biotech Profile
5.6.2 Beijing TransGen Biotech Main Business
5.6.3 Beijing TransGen Biotech Competent Cells Products, Services and Solutions
5.6.4 Beijing TransGen Biotech Competent Cells Revenue (US$ Million) & (2018-2023)
5.6.5 Beijing TransGen Biotech Recent Developments
5.7 GeneScript Corporation
5.7.1 GeneScript Corporation Profile
5.7.2 GeneScript Corporation Main Business
5.7.3 GeneScript Corporation Competent Cells Products, Services and Solutions
5.7.4 GeneScript Corporation Competent Cells Revenue (US$ Million) & (2018-2023)
5.7.5 GeneScript Corporation Recent Developments
5.8 Yeastern Biotech
5.8.1 Yeastern Biotech Profile
5.8.2 Yeastern Biotech Main Business
5.8.3 Yeastern Biotech Competent Cells Products, Services and Solutions
5.8.4 Yeastern Biotech Competent Cells Revenue (US$ Million) & (2018-2023)
5.8.5 Yeastern Biotech Recent Developments
5.9 New England Biolabs
5.9.1 New England Biolabs Profile
5.9.2 New England Biolabs Main Business
5.9.3 New England Biolabs Competent Cells Products, Services and Solutions
5.9.4 New England Biolabs Competent Cells Revenue (US$ Million) & (2018-2023)
5.9.5 New England Biolabs Recent Developments
5.10 QIAGEN N.V.
5.10.1 QIAGEN N.V. Profile
5.10.2 QIAGEN N.V. Main Business
5.10.3 QIAGEN N.V. Competent Cells Products, Services and Solutions
5.10.4 QIAGEN N.V. Competent Cells Revenue (US$ Million) & (2018-2023)
5.10.5 QIAGEN N.V. Recent Developments
5.11 OriGene Technologies
5.11.1 OriGene Technologies Profile
5.11.2 OriGene Technologies Main Business
5.11.3 OriGene Technologies Competent Cells Products, Services and Solutions
5.11.4 OriGene Technologies Competent Cells Revenue (US$ Million) & (2018-2023)
5.11.5 OriGene Technologies Recent Developments
5.12 Lucigen
5.12.1 Lucigen Profile
5.12.2 Lucigen Main Business
5.12.3 Lucigen Competent Cells Products, Services and Solutions
5.12.4 Lucigen Competent Cells Revenue (US$ Million) & (2018-2023)
5.12.5 Lucigen Recent Developments
5.13 Zymo Research
5.13.1 Zymo Research Profile
5.13.2 Zymo Research Main Business
5.13.3 Zymo Research Competent Cells Products, Services and Solutions
5.13.4 Zymo Research Competent Cells Revenue (US$ Million) & (2018-2023)
5.13.5 Zymo Research Recent Developments
5.14 Bio-Rad Laboratories
5.14.1 Bio-Rad Laboratories Profile
5.14.2 Bio-Rad Laboratories Main Business
5.14.3 Bio-Rad Laboratories Competent Cells Products, Services and Solutions
5.14.4 Bio-Rad Laboratories Competent Cells Revenue (US$ Million) & (2018-2023)
5.14.5 Bio-Rad Laboratories Recent Developments
5.15 Bioline
5.15.1 Bioline Profile
5.15.2 Bioline Main Business
5.15.3 Bioline Competent Cells Products, Services and Solutions
5.15.4 Bioline Competent Cells Revenue (US$ Million) & (2018-2023)
5.15.5 Bioline Recent Developments
5.16 Delphi Genetics
5.16.1 Delphi Genetics Profile
5.16.2 Delphi Genetics Main Business
5.16.3 Delphi Genetics Competent Cells Products, Services and Solutions
5.16.4 Delphi Genetics Competent Cells Revenue (US$ Million) & (2018-2023)
5.16.5 Delphi Genetics Recent Developments
5.17 IBA GmBH
5.17.1 IBA GmBH Profile
5.17.2 IBA GmBH Main Business
5.17.3 IBA GmBH Competent Cells Products, Services and Solutions
5.17.4 IBA GmBH Competent Cells Revenue (US$ Million) & (2018-2023)
5.17.5 IBA GmBH Recent Developments
5.18 Cell Applications
5.18.1 Cell Applications Profile
5.18.2 Cell Applications Main Business
5.18.3 Cell Applications Competent Cells Products, Services and Solutions
5.18.4 Cell Applications Competent Cells Revenue (US$ Million) & (2018-2023)
5.18.5 Cell Applications Recent Developments
5.19 BioDynamics Laboratory
5.19.1 BioDynamics Laboratory Profile
5.19.2 BioDynamics Laboratory Main Business
5.19.3 BioDynamics Laboratory Competent Cells Products, Services and Solutions
5.19.4 BioDynamics Laboratory Competent Cells Revenue (US$ Million) & (2018-2023)
5.19.5 BioDynamics Laboratory Recent Developments
5.20 Scarab Genomics
5.20.1 Scarab Genomics Profile
5.20.2 Scarab Genomics Main Business
5.20.3 Scarab Genomics Competent Cells Products, Services and Solutions
5.20.4 Scarab Genomics Competent Cells Revenue (US$ Million) & (2018-2023)
5.20.5 Scarab Genomics Recent Developments
5.21 GCC Biotech
5.21.1 GCC Biotech Profile
5.21.2 GCC Biotech Main Business
5.21.3 GCC Biotech Competent Cells Products, Services and Solutions
5.21.4 GCC Biotech Competent Cells Revenue (US$ Million) & (2018-2023)
5.21.5 GCC Biotech Recent Developments
5.22 SMOBIO Technology
5.22.1 SMOBIO Technology Profile
5.22.2 SMOBIO Technology Main Business
5.22.3 SMOBIO Technology Competent Cells Products, Services and Solutions
5.22.4 SMOBIO Technology Competent Cells Revenue (US$ Million) & (2018-2023)
5.22.5 SMOBIO Technology Recent Developments
5.23 Edge BioSystems
5.23.1 Edge BioSystems Profile
5.23.2 Edge BioSystems Main Business
5.23.3 Edge BioSystems Competent Cells Products, Services and Solutions
5.23.4 Edge BioSystems Competent Cells Revenue (US$ Million) & (2018-2023)
5.23.5 Edge BioSystems Recent Developments
6 North America
6.1 North America Competent Cells Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Competent Cells Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Competent Cells Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Competent Cells Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Competent Cells Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Competent Cells Market Dynamics
11.1 Competent Cells Industry Trends
11.2 Competent Cells Market Drivers
11.3 Competent Cells Market Challenges
11.4 Competent Cells Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market Competent Cells Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Competent Cells Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Competent Cells Market Size Share by Region (2018-2023)
    Table 4. Global Competent Cells Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Competent Cells Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Competent Cells Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Competent Cells Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Competent Cells Revenue Market Share by Type (2018-2023)
    Table 9. Global Competent Cells Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Competent Cells Revenue Market Share by Type (2024-2029)
    Table 11. North America Competent Cells Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Competent Cells Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Competent Cells Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Competent Cells Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Competent Cells Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Competent Cells Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Competent Cells Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Competent Cells Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Competent Cells Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Competent Cells Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Competent Cells Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Competent Cells Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Competent Cells Revenue Market Share by Application (2018-2023)
    Table 24. Global Competent Cells Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Competent Cells Revenue Market Share by Application (2024-2029)
    Table 26. North America Competent Cells Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Competent Cells Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Competent Cells Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Competent Cells Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Competent Cells Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Competent Cells Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Competent Cells Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Competent Cells Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Competent Cells Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Competent Cells Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Competent Cells Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Competent Cells Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Competent Cells as of 2022)
    Table 39. Date of Key Players Enter into Competent Cells Market
    Table 40. Global Competent Cells Key Players Headquarters and Area Served
    Table 41. Competent Cells Product Solution and Service
    Table 42. Global Competent Cells Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Merck KGaA Basic Information List
    Table 45. Merck KGaA Description and Business Overview
    Table 46. Merck KGaA Competent Cells Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Competent Cells Business of Merck KGaA (2018-2023)
    Table 48. Merck KGaA Recent Developments
    Table 49. Thermo Fisher Scientific Basic Information List
    Table 50. Thermo Fisher Scientific Description and Business Overview
    Table 51. Thermo Fisher Scientific Competent Cells Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Competent Cells Business of Thermo Fisher Scientific (2018-2023)
    Table 53. Thermo Fisher Scientific Recent Developments
    Table 54. Agilent Technologies Basic Information List
    Table 55. Agilent Technologies Description and Business Overview
    Table 56. Agilent Technologies Competent Cells Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Competent Cells Business of Agilent Technologies (2018-2023)
    Table 58. Agilent Technologies Recent Developments
    Table 59. Takara Bio Basic Information List
    Table 60. Takara Bio Description and Business Overview
    Table 61. Takara Bio Competent Cells Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Competent Cells Business of Takara Bio (2018-2023)
    Table 63. Takara Bio Recent Developments
    Table 64. Promega Corporation Basic Information List
    Table 65. Promega Corporation Description and Business Overview
    Table 66. Promega Corporation Competent Cells Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Competent Cells Business of Promega Corporation (2018-2023)
    Table 68. Promega Corporation Recent Developments
    Table 69. Beijing TransGen Biotech Basic Information List
    Table 70. Beijing TransGen Biotech Description and Business Overview
    Table 71. Beijing TransGen Biotech Competent Cells Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Competent Cells Business of Beijing TransGen Biotech (2018-2023)
    Table 73. Beijing TransGen Biotech Recent Developments
    Table 74. GeneScript Corporation Basic Information List
    Table 75. GeneScript Corporation Description and Business Overview
    Table 76. GeneScript Corporation Competent Cells Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Competent Cells Business of GeneScript Corporation (2018-2023)
    Table 78. GeneScript Corporation Recent Developments
    Table 79. Yeastern Biotech Basic Information List
    Table 80. Yeastern Biotech Description and Business Overview
    Table 81. Yeastern Biotech Competent Cells Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Competent Cells Business of Yeastern Biotech (2018-2023)
    Table 83. Yeastern Biotech Recent Developments
    Table 84. New England Biolabs Basic Information List
    Table 85. New England Biolabs Description and Business Overview
    Table 86. New England Biolabs Competent Cells Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Competent Cells Business of New England Biolabs (2018-2023)
    Table 88. New England Biolabs Recent Developments
    Table 89. QIAGEN N.V. Basic Information List
    Table 90. QIAGEN N.V. Description and Business Overview
    Table 91. QIAGEN N.V. Competent Cells Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Competent Cells Business of QIAGEN N.V. (2018-2023)
    Table 93. QIAGEN N.V. Recent Developments
    Table 94. OriGene Technologies Basic Information List
    Table 95. OriGene Technologies Description and Business Overview
    Table 96. OriGene Technologies Competent Cells Products, Services and Solutions
    Table 97. Revenue (US$ Million) in Competent Cells Business of OriGene Technologies (2018-2023)
    Table 98. OriGene Technologies Recent Developments
    Table 99. Lucigen Basic Information List
    Table 100. Lucigen Description and Business Overview
    Table 101. Lucigen Competent Cells Products, Services and Solutions
    Table 102. Revenue (US$ Million) in Competent Cells Business of Lucigen (2018-2023)
    Table 103. Lucigen Recent Developments
    Table 104. Zymo Research Basic Information List
    Table 105. Zymo Research Description and Business Overview
    Table 106. Zymo Research Competent Cells Products, Services and Solutions
    Table 107. Revenue (US$ Million) in Competent Cells Business of Zymo Research (2018-2023)
    Table 108. Zymo Research Recent Developments
    Table 109. Bio-Rad Laboratories Basic Information List
    Table 110. Bio-Rad Laboratories Description and Business Overview
    Table 111. Bio-Rad Laboratories Competent Cells Products, Services and Solutions
    Table 112. Revenue (US$ Million) in Competent Cells Business of Bio-Rad Laboratories (2018-2023)
    Table 113. Bio-Rad Laboratories Recent Developments
    Table 114. Bioline Basic Information List
    Table 115. Bioline Description and Business Overview
    Table 116. Bioline Competent Cells Products, Services and Solutions
    Table 117. Revenue (US$ Million) in Competent Cells Business of Bioline (2018-2023)
    Table 118. Bioline Recent Developments
    Table 119. Delphi Genetics Basic Information List
    Table 120. Delphi Genetics Description and Business Overview
    Table 121. Delphi Genetics Competent Cells Products, Services and Solutions
    Table 122. Revenue (US$ Million) in Competent Cells Business of Delphi Genetics (2018-2023)
    Table 123. Delphi Genetics Recent Developments
    Table 124. IBA GmBH Basic Information List
    Table 125. IBA GmBH Description and Business Overview
    Table 126. IBA GmBH Competent Cells Products, Services and Solutions
    Table 127. Revenue (US$ Million) in Competent Cells Business of IBA GmBH (2018-2023)
    Table 128. IBA GmBH Recent Developments
    Table 129. Cell Applications Basic Information List
    Table 130. Cell Applications Description and Business Overview
    Table 131. Cell Applications Competent Cells Products, Services and Solutions
    Table 132. Revenue (US$ Million) in Competent Cells Business of Cell Applications (2018-2023)
    Table 133. Cell Applications Recent Developments
    Table 134. BioDynamics Laboratory Basic Information List
    Table 135. BioDynamics Laboratory Description and Business Overview
    Table 136. BioDynamics Laboratory Competent Cells Products, Services and Solutions
    Table 137. Revenue (US$ Million) in Competent Cells Business of BioDynamics Laboratory (2018-2023)
    Table 138. BioDynamics Laboratory Recent Developments
    Table 139. Scarab Genomics Basic Information List
    Table 140. Scarab Genomics Description and Business Overview
    Table 141. Scarab Genomics Competent Cells Products, Services and Solutions
    Table 142. Revenue (US$ Million) in Competent Cells Business of Scarab Genomics (2018-2023)
    Table 143. Scarab Genomics Recent Developments
    Table 144. GCC Biotech Basic Information List
    Table 145. GCC Biotech Description and Business Overview
    Table 146. GCC Biotech Competent Cells Products, Services and Solutions
    Table 147. Revenue (US$ Million) in Competent Cells Business of GCC Biotech (2018-2023)
    Table 148. GCC Biotech Recent Developments
    Table 149. SMOBIO Technology Basic Information List
    Table 150. SMOBIO Technology Description and Business Overview
    Table 151. SMOBIO Technology Competent Cells Products, Services and Solutions
    Table 152. Revenue (US$ Million) in Competent Cells Business of SMOBIO Technology (2018-2023)
    Table 153. SMOBIO Technology Recent Developments
    Table 154. Edge BioSystems Basic Information List
    Table 155. Edge BioSystems Description and Business Overview
    Table 156. Edge BioSystems Competent Cells Products, Services and Solutions
    Table 157. Revenue (US$ Million) in Competent Cells Business of Edge BioSystems (2018-2023)
    Table 158. Edge BioSystems Recent Developments
    Table 159. North America Competent Cells Market Size by Country (2018-2023) & (US$ Million)
    Table 160. North America Competent Cells Market Size by Country (2024-2029) & (US$ Million)
    Table 161. Europe Competent Cells Market Size by Country (2018-2023) & (US$ Million)
    Table 162. Europe Competent Cells Market Size by Country (2024-2029) & (US$ Million)
    Table 163. Asia-Pacific Competent Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 164. Asia-Pacific Competent Cells Market Size by Region (2018-2023) & (US$ Million)
    Table 165. Asia-Pacific Competent Cells Market Size by Region (2024-2029) & (US$ Million)
    Table 166. Asia-Pacific Competent Cells Market Share by Region (2018-2023)
    Table 167. Asia-Pacific Competent Cells Market Share by Region (2024-2029)
    Table 168. Latin America Competent Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 169. Latin America Competent Cells Market Size by Country (2018-2023) & (US$ Million)
    Table 170. Latin America Competent Cells Market Size by Country (2024-2029) & (US$ Million)
    Table 171. Middle East & Africa Competent Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 172. Middle East & Africa Competent Cells Market Size by Country (2018-2023) & (US$ Million)
    Table 173. Middle East & Africa Competent Cells Market Size by Country (2024-2029) & (US$ Million)
    Table 174. Competent Cells Market Trends
    Table 175. Competent Cells Market Drivers
    Table 176. Competent Cells Market Challenges
    Table 177. Competent Cells Market Restraints
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Competent Cells Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Competent Cells Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Competent Cells Market Share by Regions: 2022 VS 2029
    Figure 4. Global Competent Cells Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Competent Cells Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Competent Cells Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Competent Cells Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Competent Cells Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Competent Cells Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Chemically Competent Cells
    Figure 11. Global Chemically Competent Cells Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Electrocompetent Cells
    Figure 13. Global Electrocompetent Cells Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Global Competent Cells Market Size Share by Type: 2022 & 2029
    Figure 15. North America Competent Cells Revenue Market Share by Type (2018-2029)
    Figure 16. Europe Competent Cells Revenue Market Share by Type (2018-2029)
    Figure 17. Asia-Pacific Competent Cells Revenue Market Share by Type (2018-2029)
    Figure 18. Latin America Competent Cells Revenue Market Share by Type (2018-2029)
    Figure 19. Middle East and Africa Competent Cells Revenue Market Share by Type (2018-2029)
    Figure 20. Subcloning & Routine Cloning Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 21. Phage Display Library Construction Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 22. Toxic/Unstable DNA Cloning Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 23. High-Throughput Cloning Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 24. Protein Expression Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 25. Mutagenesis Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 26. Single-Stranded DNA Production Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 27. Bacmid Creation Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 28. Cre-Lox Recombination (PIR1/PIR2) Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 29. Global Competent Cells Market Size Share by Application: 2022 & 2029
    Figure 30. North America Competent Cells Revenue Market Share by Application (2018-2029)
    Figure 31. Europe Competent Cells Revenue Market Share by Application (2018-2029)
    Figure 32. Asia-Pacific Competent Cells Revenue Market Share by Application (2018-2029)
    Figure 33. Latin America Competent Cells Revenue Market Share by Application (2018-2029)
    Figure 34. Middle East and Africa Competent Cells Revenue Market Share by Application (2018-2029)
    Figure 35. Competent Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 36. Global Top 5 and Top 10 Players Competent Cells Market Share in 2022
    Figure 37. North America Competent Cells Market Share by Country (2018-2029)
    Figure 38. U.S. Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 39. Canada Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 40. Germany Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 41. France Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 42. U.K. Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 43. Italy Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 44. Russia Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 45. Nordic Countries Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 46. Asia-Pacific Competent Cells Market Share by Region (2018-2029)
    Figure 47. China Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 48. Japan Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 49. South Korea Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 50. Southeast Asia Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 51. India Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 52. Australia Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 53. Latin America Competent Cells Market Share by Country (2018-2029)
    Figure 54. Mexico Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 55. Brazil Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 56. Middle East & Africa Competent Cells Market Share by Country (2018-2029)
    Figure 57. Turkey Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 58. Saudi Arabia Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 59. UAE Competent Cells Market Size (2018-2029) & (US$ Million)
    Figure 60. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Citric Acid - Global Market Insights and Sales Trends 2024

120 Pages
Type: Report
Code: QYRE-Auto-33R9027
Fri Dec 01 00:00:00 UTC 2023

Add to Cart

Laboratory Rotary Evaporators - Global Market Insights and Sales Trends 2024

120 Pages
Type: Report
Code: QYRE-Auto-10Z9254
Fri Dec 01 00:00:00 UTC 2023

Add to Cart

Geotechnical Sensors - Global Market Insights and Sales Trends 2024

120 Pages
Type: Report
Code: QYRE-Auto-17D666
Fri Dec 01 00:00:00 UTC 2023

Add to Cart

Viral Vectors and Plasmid DNA Manufacturing - Global Market Insights and Sales Trends 2024

120 Pages
Type: Report
Code: QYRE-Auto-25V7140
Fri Dec 01 00:00:00 UTC 2023

Add to Cart